Status:
COMPLETED
Clinical Study of Fecal Microbiota Transplantation in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)
Lead Sponsor:
Shanghai 10th People's Hospital
Conditions:
Small Intestinal Bacterial Overgrowth
Fecal Microbiota Transplantation
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Small intestinal bacterial overgrowth (SIBO) is defined as the presence of excessive numbers of bacteria in the small bowel causing gastrointestinal (GI) symptoms. These bacteria are usually coliforms...
Eligibility Criteria
Inclusion
- Patients with a positive breath test result upon initial admission.
- Patients presenting with abdominal symptoms.
- Patients who have stool and small intestinal fluid samples available before and after FMT.
Exclusion
- Patients with gastrointestinal malignancies.
- Patients with a history of gastrointestinal surgery.
- Patients on long-term probiotic use.
- Patients with a history of extensive antibiotic use.
Key Trial Info
Start Date :
September 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2023
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06162702
Start Date
September 10 2022
End Date
November 10 2023
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intestinal Microenvironment Treatment Center of General Surgery, Shanghai Tenth People's Hospital, Tenth People's Hospital of Tongji University
Shanghai, China